In Vivo Two-Color 2-Photon Imaging of Genetically-Tagged Reporter Cells in the Skin
July 11th, 2019
7.3K views
Morphological changes occur in immune responsive fibroblast cells following activation and promote alterations in cellular recruitment. Utilizing 2-photon imaging in conjunction with a genetically engineered Fibroblast-specific protein 1 (FSP1)-cre; tdTomato floxed-stop-floxed (TB/TB) mouse line and green fluorescently tagged lipopolysaccharide-FITC, we can illustrate highly specific uptake of lipopolysaccharide in dermal fibroblasts and morphological changes in vivo.
Overview
This study utilizes 2-photon imaging to visualize the response of fibroblast cells to inflammatory stimuli in live animals. The approach allows for real-time observation of cellular changes and recruitment dynamics.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Cell Biology
Background
- Fibroblast cells play a crucial role in immune responses.
- Understanding their behavior during inflammation is essential for therapeutic strategies.
- 2-Photon imaging provides a unique opportunity to study these cells in vivo.
- Fluorescent tagging allows for specific tracking of cellular responses.
Purpose of Study
- To visualize morphological changes in fibroblast cells upon activation.
- To assess the uptake of lipopolysaccharide in dermal fibroblasts.
- To illustrate alterations in cellular recruitment during inflammation.
Methods Used
- 2-Photon imaging technique for deep tissue visualization.
- Use of genetically engineered FSP1-cre; tdTomato floxed-stop-floxed mouse line.
- Application of green fluorescently tagged lipopolysaccharide-FITC.
- Real-time imaging of live specimens to maintain cellular integrity.
Main Results
- Demonstrated specific uptake of lipopolysaccharide in fibroblasts.
- Observed significant morphological changes in response to activation.
- Illustrated dynamic alterations in cellular recruitment in vivo.
- Provided insights into the role of fibroblasts in inflammation.
Conclusions
- 2-Photon imaging is an effective method for studying fibroblast responses.
- Findings enhance understanding of immune responses in tissue.
- Future studies can build on these insights for therapeutic applications.
Frequently Asked Questions
What is 2-Photon imaging?
2-Photon imaging is a microscopy technique that allows for deep tissue visualization in live specimens while preserving cellular integrity.
Why is fibroblast activation important?
Fibroblast activation plays a crucial role in immune responses and tissue repair during inflammation.
How does lipopolysaccharide affect fibroblasts?
Lipopolysaccharide triggers activation and morphological changes in fibroblasts, influencing their role in immune responses.
What are the advantages of using genetically engineered mice?
Genetically engineered mice allow for specific tracking of cellular behaviors and responses in vivo, enhancing experimental accuracy.
What insights can be gained from this study?
The study provides valuable insights into the dynamics of fibroblast behavior during inflammation, which can inform therapeutic strategies.
Executive Industry Relevance
Real-time in vivo two-color 2-photon imaging of genetically-tagged fibroblasts enables direct visualization of protein-receptor interactions and cellular activation dynamics within intact tissue microenvironments. This approach enhances predictive confidence in target engagement and mechanistic de-risking at the discovery stage, supporting more informed portfolio triage and early go/no-go decisions. The method's ability to capture dynamic morphological and uptake responses in live systems is highly relevant for translational research and preclinical model validation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct observation of ligand-receptor binding and cellular activation in live tissue.
- Supports mechanistic de-risking by clarifying pathway engagement and cell-type specificity.
- Improves predictive confidence for target validation by visualizing real-time cellular responses.
- Facilitates early identification of functional biomarkers linked to activation states.
Screening & Assay Development
- Provides validated biological systems for downstream screening of modulators or inhibitors.
- Delivers quantitative, reproducible imaging outputs for assay standardization.
- Enables assessment of compound effects on protein uptake and cell morphology in situ.
- Supports scalability for multiplexed imaging and comparative analysis across conditions.
Translational & Preclinical Research
- Aligns in vivo imaging outputs with disease-relevant activation and recruitment events.
- Ensures continuity from discovery through preclinical validation by tracking live cell behavior.
- Reduces translational risk by confirming target engagement in physiologically relevant contexts.
- Enables identification of dynamic biomarkers for preclinical model optimization.
Pipeline & Workflow Integration
This imaging workflow bridges early discovery, target validation, and preclinical research by providing real-time, quantitative evidence of protein-cell interactions and activation in live animal models.
- Discovery Biology: Supports hypothesis testing and pathway clarification by visualizing ligand-receptor dynamics in situ.
- Screening: Delivers reproducible, quantitative imaging data for assay development and compound evaluation.
- Analytics: Enables measurement of uptake kinetics, co-localization, and morphological changes for comparative analysis.
- Translational Research: Connects discovery findings to preclinical endpoints by tracking disease-relevant cellular responses.
- Enterprise Reuse: Establishes a reusable imaging platform for diverse target and pathway interrogation across programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes in vivo imaging protocols for reproducibility and scalability.
- Strategic Value: Enables earlier, data-driven go/no-go decisions and capital-efficient portfolio management.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of candidates with validated in vivo engagement.
Implementation Considerations
- Requires expertise in advanced in vivo imaging and genetic reporter model handling.
- Demands access to multi-photon microscopy and fluorescence detection infrastructure.
- Necessitates rigorous cross-team standardization for imaging protocols and data analysis.
- May require adaptation for different tissue types or genetic backgrounds.
- Imaging depth and motion artifacts must be managed to ensure data quality.
Biopharma FAQs
Why does null hypothesis testing matter for TLR4-LPS binding validation?
Null hypothesis testing ensures that observed LPS-FITC uptake and co-localization with TLR4-expressing fibroblasts are statistically significant and not due to random distribution, supporting robust target validation in live tissue.
How does independent variable isolation fit the 2-photon imaging workflow?
By using genetic knockout controls and selective fluorescent labeling, the protocol isolates TLR4 expression as the independent variable, enabling clear attribution of LPS uptake to specific receptor-ligand interactions.
What do quantitative time-lapse measurements of LPS uptake enable?
Quantitative time-lapse imaging provides kinetic data on protein uptake and morphological changes, allowing teams to compare activation dynamics across conditions and inform downstream screening or validation steps.
Why are replication requirements critical for cross-functional imaging studies?
Replication ensures that observed cellular responses and uptake patterns are reproducible across animals and experiments, facilitating reliable data sharing and decision-making between discovery, screening, and translational teams.
Which statistical analysis capabilities are required before imaging implementation?
Robust statistical tools are needed to analyze co-localization, uptake kinetics, and morphological changes, ensuring that imaging outputs meet quantitative thresholds for target validation and portfolio advancement.
